---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-004078"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2021-11-10T23:59:59+00:00"
generated_at: "2026-06-28T09:43:50.849042+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# RxSight Q3 2021 revenue $5.8M (+39% YoY); net loss $12.7M; FY revenue guidance $21.0-$21.4M

## Summary
- Q3 revenue $5.8M, up 39% YoY and 18% QoQ; 31 LDDs sold, installed base 161.
- Net loss $(12.7)M ($(0.68)/share) vs net income $5.9M in Q3 2020; adjusted net loss $(12.2)M ($(0.65)/share).
- Cash and investments $168.3M; long-term debt $39.6M as of Sep 30, 2021.
- FY 2021 revenue guidance $21.0M-$21.4M.

## SEC filing metadata
- accession: 0000950170-21-004078
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2021-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017021004078/0000950170-21-004078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017021004078/rxst-20211110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-004078
- JSON: https://secwatch.observer/filing/0000950170-21-004078.json
- Plain text: https://secwatch.observer/filing/0000950170-21-004078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.